Cadila Healthcare’s Q1 consolidated net profit registers 15% growth

19 Jul 2011 Evaluate

Cadila Healthcare has reported results for the quarter ended June 30, 2011

The company’s net profit for the quarter has dipped by 23.01% at Rs 152.93 crore as compared to Rs 198.64 crore for the quarter ended June 30, 2010. Its total Income too has decreased by 1.07% to Rs 790.52 crore for the quarter under review from Rs 799.11 crore for the corresponding quarter of the previous year.

On Consolidated basis, the Group ‘s net profit has registered a gain of 15.38% at Rs 229.82 crore for the quarter ended June 30, 2011 as compared to Rs 199.18 crore for the quarter ended June 30, 2010. Its total Income has increased by 10.15% to Rs 1252 crore for the quarter from Rs 1136.65 crore for the similar quarter of the previous year.

Cadila Pharmaceuticals focuses on various areas, such as formulations (human & veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

Zydus Lifesciences Share Price

911.50 -5.95 (-0.65%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×